Alternatives to Pfizer

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A biotechnology company developing genetic therapies for rare disorders.

Biopharmaceutical company developing innovative botanical drugs for addiction treatment.

Biopharmaceutical company focused on rare genetic diseases of obesity.

Vaxart is a clinical-stage biotechnology company developing oral vaccines for infectious diseases.

Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.

A global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.

Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases.

Biotechnology company focused on developing cancer immunotherapies.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing in vivo immunotherapies for autoimmune diseases and cancer.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A global leader in clinical pharmacology and bioanalytical sciences.